KIR3DL2 and neoplasm: PMBC-derived cells had malignant clones expectedly exhibiting a dominant clonotype (TRBV7-2 and TRAAV2), copy number variations, decreased expression of CD7, and aberrantly elevated expression of KIR3DL2 (CD158k) and CD70, which are known to be tumor-associated.